Pap test is a process in which cells from the surface of the cervix and the vicinity are gently removed with a little brush so that they can be examined under a microscope for cervical cancer or cell alterations that may result in cervical cancer.
According to UnivDatos Market Insights (UMI)’ research report “Global Pap Test Market”, the Pap Test Market is expected to grow at a steady rate of around 11.4% owing to a surge in the cases of cervical cancers, technological developments taking place, and a rise in the number of cancer screening programs.
Unlock Insights: Receive a Sample Research Report on the Pap Test Market - https://univdatos.com/get-a-free-sample-form-php/?product_id=35848
Other disorders, including as infections or inflammation, can also be discovered with a pap test. It is typically performed concurrently with a pelvic examination and may also be concurrent with a test for specific forms of human papillomavirus (HPV), also known as the Papanicolaou test and Pap smear. The market for pap test is expected to grow significantly owing to the increasing number of HPV cases and rising awareness regarding cervical cancers. For instance, diagnosed in more than 90% of cervical cancers, the fourth deadliest cancer in women, HPV is currently the most common pathogen responsible for female cancers, as per the study conducted on the estimated lifetime probability of acquiring human papillomavirus in the United States.
The surge in the prevalence of cervical cancers among the global population is the major factor responsible for thriving the growth of the market. For instance, according to the World Health Organization, 2021, cervical cancer is the world's fourth-most common cancer, with more than 500,000 cases diagnosed every year.
Based on application, the market is segmented into cervical cancer screening, vaginal cancer screening, and others. The cervical cancer screening category is expected to hold a major market share during the forecast period owing to the rise in the number of cases of cervical cancers worldwide and the rising need for their diagnosis using pap tests. Moreover, rising initiatives and accurate screening programs are now being implemented so that every woman with cervical disease gets the treatment she needs. WHO’s global strategy for cervical cancer elimination– endorsed by the World Health Assembly in 2020 – requires 70% of women globally to be screened regularly for cervical disease with a high-performance test, and 90% of those needing it to receive appropriate treatment. Thus, the above-mentioned factors are the significant factor driving the segmental growth during the forecast period.
Based on technology, the market is bifurcated into PCR and others. The others held a dominant share of the market in 2021. The others segment consists of colposcopy and ELISA techniques among others. The dominant share is mainly due to the high adoption rate for colposcopy examinations done for the determination of cervical cancers.
Based on end user, the market is segmented into research laboratories, diagnostic centers, hospitals & clinics, and others. The diagnostic centers segment is expected to witness significant CAGR during the forecast period due to the rising women population suffering with cervical cancer and surge in demand for diagnosis and detection of the disease.
North America to witness extensive growth
For a better understanding of the market adoption of the Pap Test industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is anticipated to dominate the global pap test market mainly due to a surge in the cases of cervical cancers, leading to the need for rising awareness related to early screening for cancers, and various initiatives brought in during the forecast period. For instance, in 2020, WHO launched the Global Strategy to Accelerate the Elimination of Cervical Cancer, which outlined three key steps: vaccination, screening, and treatment. Successful implementation of all three reduced more than 40% of new cases of the disease and 5 million related deaths by 2050. Thus, these factors are driving the regional market in the forecast period.
According to UnivDatos Market Insights (UMI)’, the key players with a considerable market share in the pap test market are Abbott, F. Hoffmann-La Roche Ltd., BD, QIAGEN, Thermo Fisher Scientific Inc., HOLOGIC, INC., Seegene Inc., Arbor Vita Corporation, Femasys Inc., Hospital Equipment Mfg. Co.
Explore the Comprehensive Research Overview, Including a Table of Contents, on the Pap Test Market - https://univdatos.com/report/pap-test-market
“Global Pap Test Market” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for the market players. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitors’ capabilities on different parameters. This will help companies in the formulation of go-to-market strategies and identifying the blue ocean for its offerings.
Contact Us:
UnivDatos Market Insights
Email - sales@univdatos.com
Website - https://univdatos.com/
Global HPV Testing & Pap Test Market, By Test Type ((HPV Testing), Follow-Up HPV Testing, Co-Testing, Primary HPV Testing, PAP Test)), Application (Cervical Cancer Screening, Vaginal Cancer Screening), End Users (Laboratories, Hospitals, Physicians’ Offices Clinics), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)– Industry Trends and Forecast to 2025The Global HPV Testing & PAP Test Market is expected to reach USD 5840.7 million by 2025, growing at a CAGR of 6.6% during the forecast period of 2018 to 2025.
Irregular findings are usually followed up by more sensitive diagnostic tests and based on the need interventions that prevent progression to cervical cancer are implemented.
All such cancers originate from Human Papillomavirus (HPV) infection.
Various developments are made by the key players for the improvement of this test In April 2018, QIAGEN N.V. launched two novel liquid biopsy panels to evaluate circulating tumor cells (CTCs) in the growing field of research into molecular mechanisms in prostate and lung cancers.
The AdnaTest ProstateCancerPanel AR-V7 Kit and AdnaTest LungCancer Kit will be introduced at the American Association for Cancer Research (AACR) 2018.
Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa and, Brazil among others.Some of the major players operating in the global HPV testing & PAP test market are Abbott Laboratories, Qiagen N.V., Roche Diagnostics, Hologic, Inc., Becton, Dickinson and Company, Quest Diagnostics, Onco Health Corporation, Seegene, Inc., Femasys Inc., Arbor Vita Corporation, QiagenN.
The Global HPV Testing and Pap Test Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 gives an evaluation of the market developments based on historical studies and comprehensive research respectively.
The market segments are also provided with an in-depth outlook of the competitive landscape and a listing of the profiled key players.The report offers a value chain analysis that gives a comprehensive outlook of the HPV testing and Pap test market.
The attractiveness analysis of this market has also been included so as to evaluate the segments that are anticipated to be profitable during the forecast period.Browse the complete Global HPV Testing And Pap Test Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 @ https://www.decisiondatabases.com/ip/6817-hpv-testing-and-pap-test-market-reportThe report also covers the complete competitive landscape of the global HPV Testing And Pap Test market with company profiles of key players such as:Abbott LaboratoriesQiagen N.V.Roche DiagnosticsHologic, Inc.Becton, Dickinson and CompanyQuest DiagnosticsOnco Health CorporationSeegene, Inc.Femasys Inc.Arbor Vita CorporationSEGMENTATIONS IN REPORT:HPV Testing And Pap Test Market Analysis By Type:HPV TestingFollow-Up HPV TestingCo-TestingHPV Primary TestingPap TestHPV Testing And Pap Test Market Analysis By Applications:Pap TestCervical Cancer ScreeningVaginal Cancer ScreeningHPV Testing And Pap Test Market Analysis By End User:LaboratoriesHospitalsPhysician’s Offices & ClinicsHPV Testing And Pap Test Market Analysis By Geography:North AmericaEuropeAsia PacificRest of the WorldDownload Free Sample Report of Global HPV Testing And Pap Test Market @ https://www.decisiondatabases.com/contact/download-sample-6817The Global HPV Testing And Pap Test Market has been exhibited in detail in the following chapters –Chapter 1 HPV Testing And Pap Test Market PrefaceChapter 2 Executive SummaryChapter 3 HPV Testing And Pap Test Industry AnalysisChapter 4 HPV Testing And Pap Test Market Value Chain AnalysisChapter 5 HPV Testing And Pap Test Market Analysis By TypeChapter 6 HPV Testing And Pap Test Market Analysis By ApplicationsChapter 7 HPV Testing And Pap Test Market Analysis By End UserChapter 8 HPV Testing And Pap Test Market Analysis By GeographyChapter 9 Competitive Landscape Of HPV Testing And Pap Test CompaniesChapter 10 Company Profiles Of HPV Testing And Pap Test IndustryPurchase the complete Global HPV Testing And Pap Test Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-6817Other Reports by DecisionDatabases.com:Global Sterility Testing Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global In-Vitro Toxicology Testing Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global Healthcare Analytical Testing Services Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026About-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.
DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors.
We provide intellectual, precise and meaningful data at a lightning speed.For more details:DecisionDatabases.comE-Mail: sales@decisiondatabases.comPhone: +91 9028057900Web: https://www.decisiondatabases.com/
